tirzepatide israel Mounjaro in Israel: Revolutionizing Weight Loss with Milan Medical Tirzepatide | DirectMeds

In the United States alone, the number of patients starting GLP-1 treatments for non-diabetic purposes has increased by 700% since 2019, with estimates suggesting that over 220,000 patients started treatment each month in 2024

Lambson says he understands the frustration of consumers who cant afford or dont have access to either brand-name or compounded versions of GLP-1 medications

But simplicity comes with trade-offs

We calculated polygenic scores from genome-wide association studies (GWAS) for 127 traits and diseases, and used these to discover molecular correlates of polygenic risk (e.g., genetic risk for inflammatory bowel disease was negatively correlated with plasma cystine)